Status:
COMPLETED
Improving Inpatient Screening for Hepatitis C
Lead Sponsor:
University of Pennsylvania
Conditions:
Hepatitis C
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will use a stepped-wedge cluster randomized clinical trial to evaluate a health system initiative to set defaults in the electronic health record admission order set to nudge inpatient hepa...
Detailed Description
The hepatitis C virus (HCV) is the leading cause of liver transplant and hepatocellular carcinoma in the United States, but direct-acting antiviral medications are now available and can cure the disea...
Eligibility Criteria
Inclusion
- Be admitted to the Hospital of the University of Pennsylvania (HUP) or Penn Presbyterian Medical Center (PPMC)
- Born between 1945 and 1965
Exclusion
- Patients will be excluded if they have already received Hepatitis C screening or have been previously diagnosed with Hepatitis C.
Key Trial Info
Start Date :
September 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 10 2021
Estimated Enrollment :
7634 Patients enrolled
Trial Details
Trial ID
NCT04525690
Start Date
September 21 2020
End Date
April 10 2021
Last Update
August 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn Medicine
Philadelphia, Pennsylvania, United States, 19103